Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995.
Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, Toyoda Y, Manabe A, Koike K, Kinoshita A, Maeda M, Ishimoto K, Sato T, Okimoto Y, Kaneko T, Kajiwara M, Sotomatsu M, Hayashi Y, Yabe H, Hosoya R, Hoshi Y, Ohira M, Bessho F, Tsunematsu Y, Tsukimoto I, Nakazawa S. Tsuchida M, et al. Among authors: sotomatsu m. Leukemia. 2000 Dec;14(12):2295-306. doi: 10.1038/sj.leu.2401937. Leukemia. 2000. PMID: 11187921 Clinical Trial.
[A study of E2A gene in childhood acute lymphoblastic leukemia].
Hayashi Y, Kikuchi A, Kobayashi S, Shikano T, Hanada R, Yamamoto K, Sotomatsu M, Ishimoto K, Sako M, Yamamori S, et al. Hayashi Y, et al. Among authors: sotomatsu m. Rinsho Ketsueki. 1994 Jan;35(1):9-13. Rinsho Ketsueki. 1994. PMID: 8139107 Japanese.
No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita A, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchida M. Igarashi S, et al. Among authors: sotomatsu m. J Clin Oncol. 2005 Sep 20;23(27):6489-98. doi: 10.1200/JCO.2005.01.982. J Clin Oncol. 2005. PMID: 16170158 Clinical Trial.
CBL mutation in childhood therapy-related leukemia.
Shiba N, Taki T, Park MJ, Nagasawa M, Kanazawa T, Takita J, Ohnishi H, Sotomatsu M, Arakawa H, Hayashi Y. Shiba N, et al. Among authors: sotomatsu m. Leukemia. 2011 Aug;25(8):1356-8. doi: 10.1038/leu.2011.75. Epub 2011 Apr 15. Leukemia. 2011. PMID: 21494262 No abstract available.
DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N, Taki T, Park MJ, Shimada A, Sotomatsu M, Adachi S, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Arakawa H, Hayashi Y. Shiba N, et al. Among authors: sotomatsu m. Br J Haematol. 2012 Feb;156(3):413-4. doi: 10.1111/j.1365-2141.2011.08879.x. Epub 2011 Oct 8. Br J Haematol. 2012. PMID: 21981547 Free article. No abstract available.
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.
Sano H, Shimada A, Taki T, Murata C, Park MJ, Sotomatsu M, Tabuchi K, Tawa A, Kobayashi R, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. Sano H, et al. Among authors: sotomatsu m. Int J Hematol. 2012 May;95(5):509-15. doi: 10.1007/s12185-012-1033-x. Epub 2012 Mar 10. Int J Hematol. 2012. PMID: 22407852
50 results